Get started
Author

Gábor Halmos

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
2018 · Lilla Hornyák, Nikoletta Dobos, et al. · Frontiers in Immunology · 311
PDF
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers
2000 · Zoltan Rekasi, Tamas Czompoly, et al. · Proceedings of the National Academy of Sciences · 176
Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers
2000 · Baodong Sun, Gabor Halmos, et al. · The Prostate · 176
High Incidence of Receptors for Luteinizing Hormone-releasing Hormone (lhrh) and Lhrh Receptor Gene Expression in Human Prostate Cancers
2000 · GABOR HALMOS, JOSÉ M. ARENCIBIA, et al. · The Journal of Urology · 163
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
1998 · Attila Nagy, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 145
Peptide analogs in the therapy of prostate cancer
2000 · Andrew V. Schally, Ana Maria Comaru-Schally, et al. · The Prostate · 121
The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
2005 · Alexandre Havt, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 119
Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities
1999 · József L. Varga, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 97
Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
1994 · Y Qin, T Ertl, et al. · PubMed · 95
RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases
2017 · László Halász, Zsolt Karányi, et al. · Genome Research · 93
PDF
The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers
2000 · Baodong Sun, Andrew V. Schally, et al. · Regulatory Peptides · 91
Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
1997 · Attila Nagy, Patricia Armatis, et al. · Proceedings of the National Academy of Sciences · 88
Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone
2000 · Gabor Halmos, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 86
Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities
2013 · Renzhi Cai, Andrew V. Schally, et al. · Peptides · 85
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia
2010 · Ferenc G. Rick, Andrew V. Schally, et al. · The Prostate · 80
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma
1997 · Andreas Jungwirth, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 79
Effect of somatostatin analog RC‐160 and bombesin/gastrin releasing peptide antagonist RC‐3095 on growth of PC‐3 human prostate‐cancer xenografts in nude mice
1993 · Jacek Pinski, Andrew V. Schally, et al. · International Journal of Cancer · 79
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia
2011 · Ferenc G. Rick, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 78
Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice
2000 · Zsuzsanna Kahán, Zsuzsanna Kahán, et al. · Breast Cancer Research and Treatment · 75
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor
2003 · Hippokratis Kiaris, Ioulia Chatzistamou, et al. · Proceedings of the National Academy of Sciences · 74
Inhibition of growth of MKN45 human gastric‐carcinoma xenografts in nude mice by treatment with bombesin/gastrin‐releasing‐peptide antagonist (RC‐3095) and somatostatin analogue RC‐160
1994 · Jucek Pinski, Gabor Halmos, et al. · International Journal of Cancer · 74
Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs
2002 · Hippokratis Kiaris, Andrew V. Schally, et al. · Proceedings of the National Academy of Sciences · 73
Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Human Prostate Cancer
2002 · Gabor Halmos, Andrew V. Schally, et al. · The Journal of Clinical Endocrinology & Metabolism · 68
Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone
2001 · Ioulia Chatzistamou, Andrew V Schally, et al. · Anti-Cancer Drugs · 66
Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways
2000 · Artur Plonowski, Andrew V. Schally, et al. · The Prostate · 64
Works count: 194
Citation count: 6,149
H-index: 45
I10-index: 132
Year
Topic
Type